Ephedra MDL Nears End With Score Of Dismissals

Law360, New York (May 8, 2008, 12:00 AM EDT) -- The multidistrict litigation over diet pill ephedra appears to be nearing the end, with a judge agreeing to dismiss hundreds of product liability suits against Metabolife International Inc. that alleged the company's weight loss supplement caused heart attacks, stroke and even death.

On Thursday, U.S. District Judge Jed Rakoff approved the dismissal of 254 Metabolife cases at a status conference in Manhattan, leaving just one suit left to be arbitrated as the long-standing litigation continues to wind down.

“I remember when this was a popular monthly...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.